Show simple item record

dc.contributor.advisorRoger G. Mark.en_US
dc.contributor.authorChen, Tiffanyen_US
dc.contributor.otherMassachusetts Institute of Technology. Dept. of Electrical Engineering and Computer Science.en_US
dc.date.accessioned2010-03-25T15:00:29Z
dc.date.available2010-03-25T15:00:29Z
dc.date.copyright2009en_US
dc.date.issued2009en_US
dc.identifier.urihttp://hdl.handle.net/1721.1/53096
dc.descriptionThesis (M. Eng.)--Massachusetts Institute of Technology, Dept. of Electrical Engineering and Computer Science, 2009.en_US
dc.descriptionIncludes bibliographical references (p. 115-118).en_US
dc.description.abstractThe effect of signal quality on the accuracy of cardiac output (CO) estimation from arterial blood pressure (ABP) was evaluated using data from the Multi-Parameter Intelligent Patient Monitoring for Intensive Care (MIMIC) II database. Thermodilution CO (TCO) was the gold standard, and a total of 121 records with 1,497 TCO measurements were used. Six lumped-parameter and systolic area CO estimators were tested, using ABP features and a robust heart rate (HR) estimate. Signal quality indices for ABP and HR were calculated using previously described metrics. For retrospective analysis, results showed that the Liljestrand estimator yielded the lowest error for all levels of signal quality and for any single estimator when using five or more calibration points. Increasing signal quality decreased error and only marginally reduced the amount of available data, as a signal quality level of 90% preserved sufficient data for almost continuous CO estimation. At the recommended signal quality thresholds, the lowest gross root mean square normalized error (RMSNE) was found to be 15.4% (or 0.74 L/min) and average RMSNE was 13.7% (0.71 L/min). Based on these results, a linear combination (LC) of the six CO estimation methods was developed and proved superior to all other methods when up to 13 TCO calibration values were used. The clinical utility of the CO estimates were examined by correlating changes in four vasoactive medication doses with corresponding changes in estimated resistance, which was derived from mean ABP and estimated CO.en_US
dc.description.abstract(cont.) Both the Liljestrand estimator and the LC estimator were used to estimate CO. Regression analysis failed to show a clear correlation between dose level and estimated resistance for either estimator except for neosynephrine, revealing the limitations of current SQI methods in ensuring signal fidelity. Examples of types of non-physiological or artifactual ABP waveforms are shown, and a potential damping detection method is proposed.en_US
dc.description.statementofresponsibilityby Tiffany Chen.en_US
dc.format.extent118 p.en_US
dc.language.isoengen_US
dc.publisherMassachusetts Institute of Technologyen_US
dc.rightsM.I.T. theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. See provided URL for inquiries about permission.en_US
dc.rights.urihttp://dspace.mit.edu/handle/1721.1/7582en_US
dc.subjectElectrical Engineering and Computer Science.en_US
dc.titleCardiac output estimation from arterial blood pressure waveforms using the MIMIC II databaseen_US
dc.title.alternativeCO estimation from ABP waveforms using the Multi-Parameter Intelligent Patient Monitoring for Intensive Care 2 databaseen_US
dc.typeThesisen_US
dc.description.degreeM.Eng.en_US
dc.contributor.departmentMassachusetts Institute of Technology. Department of Electrical Engineering and Computer Science
dc.identifier.oclc502428002en_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record